Abbott Laboratories (ABT) Change in Acquisitions & Divestments (2017)
Abbott Laboratories' (ABT) quarterly Change in Acquisitions & Divestments came in at $727.0 million in Q4 2017, up 1271.7% quarter-over-quarter from $53.0 million in Q3 2017.
Powered by 
Analysis
Abbott Laboratories (ABT) Change in Acquisitions & Divestments (2017) Analysis & Trends
Abbott Laboratories has disclosed Change in Acquisitions & Divestments across 1 years of filings, most recently posting $727.0 million for Q4 2017.
- In Q4 2017, Change in Acquisitions & Divestments changed N/A year-over-year to $727.0 million; the TTM figure through Dec 2017 stood at $2.7 billion (changed N/A YoY), while the FY2025 annual figure was $3.0 million, down 89.29% from the prior year.
- Change in Acquisitions & Divestments came in at $727.0 million for Q4 2017 at Abbott Laboratories, up from $53.0 million in the prior quarter.
- In the past five years, Change in Acquisitions & Divestments ranged from a high of $1.7 billion in Q1 2017 to a low of $53.0 million in Q3 2017.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 177.43 Bn | 172.48 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 139.20 Bn | 134.11 Bn | 1.96 Bn |
| 3 | Medtronic | 118.01 Bn | 109.81 Bn | 6.34 Bn |
| 4 | Stryker | 105.44 Bn | 101.96 Bn | 4.50 Bn |
| 5 | Boston Scientific | 62.90 Bn | 62.60 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 50.87 Bn | 46.72 Bn | 1.35 Bn |
| 7 | Dexcom | 33.72 Bn | 31.77 Bn | 830.00 Mn |
| 8 | Resmed | 32.45 Bn | 30.98 Bn | 861.22 Mn |
| 9 | Alcon | 31.70 Bn | 30.25 Bn | 1.68 Bn |
| 10 | Steris | 20.01 Bn | 19.54 Bn | 684.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2017 | 727.00 Mn |
| Sep 30, 2017 | 53.00 Mn |
| Jun 30, 2017 | 239.00 Mn |
| Mar 31, 2017 | 1.69 Bn |